Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Noel Barrett"'
Autor:
Sofie Rutsaert, Jean-Marc Steens, Paul Gineste, Basiel Cole, Sam Kint, P. Noel Barrett, Jamal Tazi, Didier Scherrer, Hartmut J. Ehrlich, Linos Vandekerckhove
Publikováno v:
Journal of Virus Eradication, Vol 5, Iss 1, Pp 10-22 (2019)
Objectives: To assess the safety and tolerability as well as antiretroviral impact of ABX464, an oral investigational drug with a novel mechanism of HIV-1 inhibition (ClinicalTrials.gov NCT02735863). Methods: Randomised, double-blind, placebo-control
Externí odkaz:
https://doaj.org/article/3ef3f0db63364cc288365e8f7330998c
Autor:
Didier Scherrer, Noel Barrett, Luc Teyton, Tillman Pearce, Josianne Nitcheu, Philippe Pouletty, Julien Santo, Hartmut J. Ehrlich
Publikováno v:
Molecular Cancer Therapeutics. 21:1788-1797
Immune checkpoint blockers (ICB) provide a promising approach to antitumor immunotherapy through blockade of immunosuppressive pathways. The synthetic glycolipid, ABX196, is a potent stimulator of invariant natural killer T cells (iNKT), a small subs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9511278906cbb4781ed51358308534dc
https://doi.org/10.1158/1535-7163.mct-22-0183
https://doi.org/10.1158/1535-7163.mct-22-0183
Publikováno v:
Expert Review of Vaccines, Vol 16, Iss 9, Pp 883-894 (2017)
Introduction: Rapid development and production of vaccines against emerging diseases requires well established, validated, robust technologies to allow industrial scale production and accelerated licensure of products. Areas covered: A versatile Vero
Externí odkaz:
https://doaj.org/article/a26917a1de6c4d3d95e7b0adb5724657
Autor:
Hartmut J. Ehrlich, Julien Santo, Philippe Pouletty, Josianne Nitcheu, Tillman Pearce, Luc Teyton, Noel Barrett, Didier Scherrer
Supplementary Figure from Demonstration of the Antitumor Activity of the iNKT Agonist ABX196, a Novel Enhancer of Cancer Immunotherapy, in Melanoma and Hepatocarcinoma Mouse Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::756179482cb9b7fcd36a3727c5756534
https://doi.org/10.1158/1535-7163.22523904.v1
https://doi.org/10.1158/1535-7163.22523904.v1
Autor:
Hartmut J. Ehrlich, Julien Santo, Philippe Pouletty, Josianne Nitcheu, Tillman Pearce, Luc Teyton, Noel Barrett, Didier Scherrer
Supplementary Data from Demonstration of the Antitumor Activity of the iNKT Agonist ABX196, a Novel Enhancer of Cancer Immunotherapy, in Melanoma and Hepatocarcinoma Mouse Models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::609130139a65ecaaa5d286825fc3a9af
https://doi.org/10.1158/1535-7163.22523910.v1
https://doi.org/10.1158/1535-7163.22523910.v1
Autor:
Walter Wodal, Michael G Schwendinger, Helga Savidis-Dacho, Brian A Crowe, Christine Hohenadl, Richard Fritz, Peter Brühl, Daniel Portsmouth, Anita Karner-Pichl, Dalida Balta, Leopold Grillberger, Otfried Kistner, P Noel Barrett, M Keith Howard
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0113963 (2015)
BackgroundA novel avian H7N9 virus with a high case fatality rate in humans emerged in China in 2013. We evaluated the immunogenicity and protective efficacy of a candidate Vero cell culture-derived whole-virus H7N9 vaccine in small animal models.Met
Externí odkaz:
https://doaj.org/article/2bb777705a7545578c212cdb0bec60d6
Autor:
Annett Hessel, Helga Savidis-Dacho, Sogue Coulibaly, Daniel Portsmouth, Thomas R Kreil, Brian A Crowe, Michael G Schwendinger, Andreas Pilz, P Noel Barrett, Falko G Falkner, Birgit Schäfer
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e88340 (2014)
BACKGROUND: The availability of a universal influenza vaccine able to induce broad cross-reactive immune responses against diverse influenza viruses would provide an alternative to currently available strain-specific vaccines. We evaluated the abilit
Externí odkaz:
https://doaj.org/article/fe46820da6be43fb9b924fc38d53fccf
Autor:
Maria O'Rourke, Andreas Traweger, Lara Lusa, Dasa Stupica, Vera Maraspin, P Noel Barrett, Franc Strle, Ian Livey
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e63968 (2013)
B. burgdorferi sensu stricto, B. afzelii, B. garinii and B. bavariensis are the principal species which account for Lyme borreliosis (LB) globally. We have developed an internally controlled duplex quantitative real time PCR assay targeting the Borre
Externí odkaz:
https://doaj.org/article/6c34e7ac6f344171adbc01d80c254e21
Autor:
Michael G Schwendinger, Maria O'Rourke, Andreas Traweger, Helga Savidis-Dacho, Andreas Pilz, Daniel Portsmouth, Ian Livey, P Noel Barrett, Brian A Crowe
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e79022 (2013)
For clinical development of a novel multivalent OspA vaccine against Lyme borreliosis, serological assays are required which can be used to establish immune correlates of protection against infection with Borrelia.Four assays (an OspA IgG ELISA, a co
Externí odkaz:
https://doaj.org/article/f170d856f9814aa49efee399e5f88620
Autor:
Birgit Schäfer, Georg W Holzer, Alexandra Joachimsthaler, Sogue Coulibaly, Michael Schwendinger, Brian A Crowe, Thomas R Kreil, P Noel Barrett, Falko G Falkner
Publikováno v:
PLoS ONE, Vol 6, Iss 9, p e24505 (2011)
BACKGROUND: Currently existing yellow fever (YF) vaccines are based on the live attenuated yellow fever virus 17D strain (YFV-17D). Although, a good safety profile was historically attributed to the 17D vaccine, serious adverse events have been repor
Externí odkaz:
https://doaj.org/article/8754ddabd43445ef9a1b4f87c1302bc2